Therefore, we stimulated HCC cells using recombinant human HMGB1 protein and treated them with HMGB1 translocation inhibitor (ethyl pyruvate, EP) under hypoxia [39]. The gene discussed is HMGB1; the disease is hepatocellular carcinoma.